↓ Skip to main content

Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis

Overview of attention for article published in BMC Cancer, June 2010
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
70 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis
Published in
BMC Cancer, June 2010
DOI 10.1186/1471-2407-10-252
Pubmed ID
Authors

Tao Xu, Juxiang Chen, Yicheng Lu, Johannes EA Wolff

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
Ecuador 1 1%
Unknown 67 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 23%
Student > Ph. D. Student 6 9%
Student > Master 5 7%
Student > Bachelor 5 7%
Other 5 7%
Other 15 21%
Unknown 18 26%
Readers by discipline Count As %
Medicine and Dentistry 34 49%
Nursing and Health Professions 4 6%
Agricultural and Biological Sciences 3 4%
Engineering 2 3%
Neuroscience 2 3%
Other 4 6%
Unknown 21 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2012.
All research outputs
#7,552,525
of 23,039,416 outputs
Outputs from BMC Cancer
#2,097
of 8,368 outputs
Outputs of similar age
#34,388
of 96,770 outputs
Outputs of similar age from BMC Cancer
#26
of 68 outputs
Altmetric has tracked 23,039,416 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,368 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 96,770 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.